世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5991 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パリビズマブ、リバビリン、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・呼吸器合胞体ウイルス（RSV）治療薬の市場動向 ・企業の競争状況、市場シェア ・呼吸器合胞体ウイルス（RSV）治療薬の種類別市場規模と予測2016-2027（パリビズマブ、リバビリン、その他） ・呼吸器合胞体ウイルス（RSV）治療薬の用途別市場規模と予測2016-2027（病院薬局、ドラッグストア、小売薬局、その他） ・呼吸器合胞体ウイルス（RSV）治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器合胞体ウイルス（RSV）治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器合胞体ウイルス（RSV）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器合胞体ウイルス（RSV）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器合胞体ウイルス（RSV）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、AstraZeneca、Merck、AbbVie、Bausch Health、GlaxoSmithKline、ReViral、Gilead Sciences、Teva Pharmaceutical） ・結論

Market Analysis and Insights: Global Respiratory Syncytial Virus(RSV) Therapeutics Market
The global Respiratory Syncytial Virus(RSV) Therapeutics market size is projected to reach US$ 837.5 million by 2027, from US$ 564.7 million in 2020, at a CAGR of 5.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Syncytial Virus(RSV) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Syncytial Virus(RSV) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Syncytial Virus(RSV) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Syncytial Virus(RSV) Therapeutics market.

Global Respiratory Syncytial Virus(RSV) Therapeutics Scope and Market Size
Respiratory Syncytial Virus(RSV) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus(RSV) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sale Channel in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Palivizumab
Ribavirin
Others

Segment by Sale Channel
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
AstraZeneca
Merck
AbbVie
Bausch Health
GlaxoSmithKline
ReViral
Gilead Sciences
Teva Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Palivizumab
1.2.3 Ribavirin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Perspective (2016-2027)
2.2 Respiratory Syncytial Virus(RSV) Therapeutics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Syncytial Virus(RSV) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Syncytial Virus(RSV) Therapeutics Industry Dynamic
2.3.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Trends
2.3.2 Respiratory Syncytial Virus(RSV) Therapeutics Market Drivers
2.3.3 Respiratory Syncytial Virus(RSV) Therapeutics Market Challenges
2.3.4 Respiratory Syncytial Virus(RSV) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus(RSV) Therapeutics Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus(RSV) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus(RSV) Therapeutics Revenue
3.4 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus(RSV) Therapeutics Revenue in 2020
3.5 Respiratory Syncytial Virus(RSV) Therapeutics Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus(RSV) Therapeutics Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus(RSV) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Syncytial Virus(RSV) Therapeutics Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Respiratory Syncytial Virus(RSV) Therapeutics Breakdown Data by Sale Channel
5.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Historic Market Size by Sale Channel (2016-2021)
5.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Sale Channel (2022-2027)

6 North America
6.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
6.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
6.2.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
6.3 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
6.3.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
6.3.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
6.3.3 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
6.4 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
6.4.1 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
7.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
7.2.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
7.3.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
7.3.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
7.3.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
7.4 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
7.4.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
8.3.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
8.3.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
8.3.3 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
8.4 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
9.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
9.2.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
9.3.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
9.3.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
9.3.3 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
9.4 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
9.4.1 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
10.3.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021)
10.3.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027)
10.3.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2027)
10.4 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.1.4 Roche Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.1.5 Roche Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.3.4 Merck Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.4.4 AbbVie Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.5.4 Bausch Health Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 ReViral
11.7.1 ReViral Company Details
11.7.2 ReViral Business Overview
11.7.3 ReViral Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.7.4 ReViral Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.7.5 ReViral Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.8.4 Gilead Sciences Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Introduction
11.9.4 Teva Pharmaceutical Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Palivizumab
Table 3. Key Players of Ribavirin
Table 4. Key Players of Others
Table 5. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth by Sale Channel (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Regions (2022-2027)
Table 11. Respiratory Syncytial Virus(RSV) Therapeutics Market Trends
Table 12. Respiratory Syncytial Virus(RSV) Therapeutics Market Drivers
Table 13. Respiratory Syncytial Virus(RSV) Therapeutics Market Challenges
Table 14. Respiratory Syncytial Virus(RSV) Therapeutics Market Restraints
Table 15. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Respiratory Syncytial Virus(RSV) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus(RSV) Therapeutics as of 2020)
Table 18. Ranking of Global Top Respiratory Syncytial Virus(RSV) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Respiratory Syncytial Virus(RSV) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Respiratory Syncytial Virus(RSV) Therapeutics Product Solution and Service
Table 22. Date of Enter into Respiratory Syncytial Virus(RSV) Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Share by Sale Channel (2016-2021) & (US$ Million)
Table 29. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Sale Channel (2016-2021)
Table 30. Global Respiratory Syncytial Virus(RSV) Therapeutics Forecasted Market Size by Sale Channel (2022-2027) (US$ Million)
Table 31. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Sale Channel (2022-2027) & (US$ Million)
Table 32. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million)
Table 35. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million)
Table 36. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million)
Table 41. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million)
Table 42. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million)
Table 47. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million)
Table 53. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million)
Table 54. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2016-2021) (US$ Million)
Table 59. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 65. Roche Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 70. AstraZeneca Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 75. Merck Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 80. AbbVie Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Bausch Health Company Details
Table 83. Bausch Health Business Overview
Table 84. Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 85. Bausch Health Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Bausch Health Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 90. GlaxoSmithKline Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. ReViral Company Details
Table 93. ReViral Business Overview
Table 94. ReViral Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 95. ReViral Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 96. ReViral Recent Development
Table 97. Gilead Sciences Company Details
Table 98. Gilead Sciences Business Overview
Table 99. Gilead Sciences Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Gilead Sciences Recent Development
Table 101. Teva Pharmaceutical Company Details
Table 102. Teva Pharmaceutical Business Overview
Table 103. Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Product
Table 104. Teva Pharmaceutical Revenue in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceutical Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Palivizumab Features
Figure 3. Ribavirin Features
Figure 4. Others Features
Figure 5. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Others Case Studies
Figure 10. Respiratory Syncytial Virus(RSV) Therapeutics Report Years Considered
Figure 11. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Players in 2020
Figure 16. Global Top Respiratory Syncytial Virus(RSV) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus(RSV) Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus(RSV) Therapeutics Revenue in 2020
Figure 18. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel (2016-2027)
Figure 23. North America Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel (2016-2027)
Figure 29. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel (2016-2027)
Figure 39. Asia-Pacific Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Region (2016-2027)
Figure 40. China Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel (2016-2027)
Figure 49. Latin America Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Sale Channel (2016-2027)
Figure 55. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Respiratory Syncytial Virus(RSV) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 63. Bausch Health Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 65. ReViral Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 66. Gilead Sciences Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 67. Teva Pharmaceutical Revenue Growth Rate in Respiratory Syncytial Virus(RSV) Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---